U.S. Markets open in 2 hrs 55 mins

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
317.93-0.25 (-0.08%)
At close: 4:00PM EDT
People also watch
CELGREGNGILDAMGNALXN
Full screen
Previous Close318.18
Open318.43
Bid313.00 x 100
Ask323.30 x 100
Day's Range316.46 - 319.44
52 Week Range244.28 - 330.00
Volume779,263
Avg. Volume1,360,978
Market Cap67.22B
Beta0.50
PE Ratio (TTM)20.86
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Profit From the Biogen Inc (BIIB) Stock Dip!
    InvestorPlace20 hours ago

    Profit From the Biogen Inc (BIIB) Stock Dip!

    Biogen Inc (NASDAQ:BIIB) stock had a fantastic start to September with a 15% rally. Clearly, this is a momentum stock, so it will never give us a clear signal for entry. More often than not, traders tend to overshoot with the price action of momentum stocks.

  • Apple Leads 7 Top Stocks Holding In Buy Range
    Investor's Business Dailyyesterday

    Apple Leads 7 Top Stocks Holding In Buy Range

    With the market grinding higher, some breakouts struggle. But Apple, Microsoft, Biogen, Alexion Pharmaceuticals, Wynn Resorts and Electronic Arts are holding in buy zones after breaking out several days or weeks ago.

  • Barrons.com2 days ago

    Gilead Sciences: Is The Kite Deal Too Little, Too Late?

    Last month, Gilead Sciences (GILD) made big news when it announced the acquisition of Kite Pharma (KITE). For the most part, analysts were bullish on the deal, with the noted exception being Leerink's Geoffrey Porges and Bradley Canino. The pair penned a note late last month explaining why they were not excited by Gilead’s latest purchase.